Reata Pharma
(RETA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -247,752 | -181,976 | -116,520 | -48,939 | -290,170 |
| Depreciation Amortization | 8,681 | 6,701 | 4,725 | 767 | 2,306 |
| Accounts payable and accrued liabilities | 2,879 | 7,033 | 9,355 | 10,668 | -2,114 |
| Other Working Capital | -172,683 | -169,053 | -171,263 | -12,308 | 10,332 |
| Other Operating Activity | 86,535 | 60,095 | 36,596 | 8,639 | 28,495 |
| Operating Cash Flow | $-322,340 | $-277,200 | $-237,107 | $-41,173 | $-251,151 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -927 | -539 | -384 | -85 | -2,673 |
| Investing Cash Flow | $-927 | $-539 | $-384 | $-85 | $-2,673 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -167,170 | -167,170 | -167,170 | N/A | 75,000 |
| Common Stock Issued | 351,098 | 65,277 | 57,185 | 1,422 | 505,898 |
| Other Financing Activity | 293,165 | 293,571 | 293,571 | 0 | -540 |
| Financing Cash Flow | $477,093 | $191,678 | $183,586 | $1,422 | $580,358 |
| Beginning Cash Position | 664,324 | 664,324 | 664,324 | 664,324 | 337,790 |
| End Cash Position | 818,150 | 578,263 | 610,419 | 624,488 | 664,324 |
| Net Cash Flow | $153,826 | $-86,061 | $-53,905 | $-39,836 | $326,534 |
| Free Cash Flow | |||||
| Operating Cash Flow | -322,340 | -277,200 | -237,107 | -41,173 | -251,151 |
| Capital Expenditure | -927 | -539 | -384 | -85 | -2,673 |
| Free Cash Flow | -323,267 | -277,739 | -237,491 | -41,258 | -253,824 |